This webinar will discuss how with the vast amount of data available today, medical affairs organizations are tasked with continuously enhancing their ability to gather, analyze and derive insights from various data sources.
In this episode, Ariel Katz, co-Founder and CEO of H1, provides a more linear and streamlined vision for how Medical Affairs can impact patient outcomes — and how to measure the results of our actions.
This webinar serves as guidance for how to overcome barriers to access patients compliantly.
This webinar program will focus on the innovative applications of internal performance management platforms such as the Medical Productivity Index (MPI) and external events, namely the 2022 Medical Affairs Innovation Olympics in pharma that illustrate examples of more continuous, real time feedback on performance, new data science analytics driven analysis of performance, more even distribution of accountability, and increased resources to accelerate learning and development.
In today’s episode, we speak with Chris Medieros about how to maximize your organization’s presence and impact at congresses.
In this webinar, Panelists will share their insights on omnichannel considerations in Medical Affairs.
In this episode of the Elevate podcast series, MAPS speaks with experts about tackling the challenges of an expanding world and understanding who is communicating research by measuring Share of Voice.
In 2022, organizations gained ground in patient trust, decentralized clinical trials, virtual tools, and diverse conversations throughout the product development process. So – now what?
In this webinar, we will discover how Medical Affairs teams are evolving from an executional hub to a strategic pillar, resonating and reconciling the voice of the patient and clinicians, and driving insights to their organization.
In this webinar, we aim to gather insights from expert speakers who will cover practical lived examples of navigating the landscape, cross functional partnership for effective results, challenges that still persist, and future implications addressing the need to establish global guidelines. Perspectives from GPP guidelines, industry/patient experience, and from publishers will be the main focus.